Human neutralizing antibodies elicited by SARS-CoV-2 infection
2020 · Nature · 1,823 citations
https://doi.org/10.1038/s41586-020-2380-z
R
Ruoke Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
3.7K
Citations
21
h-index
27
i10-index
Ruoke Wang is an academic researcher from Comprehensive Cardiovascular. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Monoclonal and Polyclonal Antibodies Research. The author has an h-index of 21, co-authored 37 publications.
ORCID: 0000-0002-8040-7913Papers by this author
worksDisruption of glial cell development by Zika virus contributes to severe microcephalic newborn mice
2018 · Cell Discovery · 61 citations
https://doi.org/10.1038/s41421-018-0042-1
Potent neutralizing monoclonal antibodies against Ebola virus infection
2016 · Scientific Reports · 49 citations
https://doi.org/10.1038/srep25856
RBD trimer mRNA vaccine elicits broad and protective immune responses against SARS-CoV-2 variants
2022 · iScience · 36 citations
https://doi.org/10.1016/j.isci.2022.104043
A Single Injection of Human Neutralizing Antibody Protects against Zika Virus Infection and Microcephaly in Developing Mouse Embryos
2018 · Cell Reports · 29 citations
https://doi.org/10.1016/j.celrep.2018.04.005
Structural Basis for Neutralization and Protection by a Zika Virus-Specific Human Antibody
2019 · Cell Reports · 25 citations
https://doi.org/10.1016/j.celrep.2019.02.062
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat